SurgMark is committed to developing innovative solutions for the diagnosis and therapy of breast cancer and other tumor diseases. With our latest tool SchurSign we combine know-how from breast surgery and biomaterial research.
Category
Biotechnology / Pharma
Sub Category
diagnostics, drug discovery / development / production / retail